Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Inogen (INGN) has provided an announcement.
Inogen, Inc. is set to part ways with Dr. Stanislav Glezer, their Executive Vice President of R&D and Chief Medical Officer, by May 3, 2024. The departure is a mutual decision, and Dr. Glezer is expected to receive benefits aligned with his existing employment and severance agreement. Details of the separation will be disclosed in a future filing with the Securities and Exchange Commission.
For an in-depth examination of INGN stock, go to TipRanks’ Stock Analysis page.
